Press release
Presbyopia Market Size in 7MM was USD 17,883 Million in 2021
The Presbyopia market report provides current treatment practices, emerging drugs, market share of the individual therapies, and current and forecasted 7MM Presbyopia market size from 2019 to 2032. The Report also covers current Presbyopia treatment practice, market drivers, market barriers, SWOT analysis, reimbursement, market access, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Key takeaways from the Presbyopia Market Report
• According to DelveInsight analysis, prevalence of Presbyopia is higher in females than males.
• In 2021, Japan had approximately 34,568,372 total prevalent cases of Presbyopia.
• The leading Presbyopia Market Companies include AbbVie, Eyenovia, Orasis Pharmaceuticals, Novartis, Visus Therapeutics, LENZ Therapeutics, Glaukos Corporation, Ocuphire Pharma, and others.
• Promising Presbyopia Pipeline Therapies include Phentolamine Opthalmic Solution 0.75%, Low dose pilocarpine, Pilocarpine HCl, CSF-1, Pilocarpine HCl Ophthalmic Solution, Pilocarpine HCl Ophthalmic Solution, Pilocarpine Ophthalmic, and others.
For more insights into the Presbyopia Market Landscape, visit Presbyopia Market Therapeutics Landscape @ https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Presbyopia Overview
Presbyopia is a normal part of aging wherein your eyes gradually lose the ability to see things clearly up close. The term "presbyopia" comes from a Greek word which means "old eye." Most people begin to notice the effect of presbyopia sometime after the age of 40 as the lenses of the eyes naturally lose their elasticity due to the aging process.
Recent Developmental Activities in the Presbyopia Treatment Landscape
• CSF-1 is a corrective eye drop being developed by Orasis Pharmaceuticals for offering an alternative to reading glasses and intrusive surgical procedures to enhance the quality of life for people with presbyopia. It is being developed to improve near visual acuity by pupil modulation, resulting in a "pinhole effect" and an increase in the depth of field, thus increasing the ability to focus on near objects. Recently, in January 2023, Orasis Pharmaceuticals submitted a NDA to the US FDA for investigational CSF-1 (low dose pilocarpine hydrochloride 0.4%) based on data from the Phase III NEAR-1 and NEAR-2 clinical trials.
• Nyxol developed by Ocuphire Pharma is a preservative-free ophthalmic solution that contains 0.75% phentolamine (1% phentolamine mesylate), a nonselective alpha-adrenergic antagonist which inhibits the contraction of the smooth muscle of the iris. It is being developed as a single drop as well as an adjunct therapy for the treatment of presbyopia. Recently, the company initiated the VEGA-2 Phase III program for investigating Nyxol alone and Nyxol with low-dose pilocarpine (LDP) as an adjunctive treatment for the potential treatment of presbyopia. Nyxol is responsible for iris dilator muscle inhibition and pilocarpine for iris sphincter muscle activation. Ocuphire also entered into a global license agreement with FamyGen Life Sciences (recently acquired by Viatris, for the development and commercialization of Nyxol in US, Europe, and Japan.
• VT-101/Brimochol (carbachol + brimonidine tartrate), is a lead investigational proprietary pupil-modulating eye being developed by Visus Therapeutics for adults who suffer from presbyopia. Carbachol is a cholinergic agent that increases the depth of field, while brimonidine tartrate is an alpha-2 agonist that prevents iris dilation and inhibits ciliary body contraction. Together they produce a "pinhole effect,". Brimonidine mitigates the side effects typically associated with cholinergic agents on the ciliary body, such as headache, brow ache, and myopic shift. Additionally, it also prolongs the pinhole effect of carbachol on the iris sphincter muscle by altering aqueous dynamics. Presently Phase III clinical trials for the safety and efficacy of Brimochol and BRIMOCHOL PF in Presbyopia patients are ongoing.
Presbyopia Epidemiology Segmentation in the 7MM
• Total Presbyopia Prevalent Cases
• Total Presbyopia Age-specific Cases
• Presbyopia Gender-specific Cases
• Total Presbyopia Diagnosed Cases
• Presbyopia Severity Specific Cases
Download the report to understand which factors are driving Presbyopia epidemiology trends, visit here for Presbyopia Epidemiological Insights @ https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Presbyopia Treatment Market
The goal of treatment is to compensate for the inability of your eyes to focus on nearby objects. Treatment options include wearing corrective eyeglasses (spectacle lenses) or contact lenses, undergoing refractive surgery, or getting lens implants for presbyopia. Pharmacological treatment of presbyopia is based on using ophthalmic drops, which by the impact on the ciliary muscle, changes the pupil size and elasticity, improving near vision.
Presbyopia Market Insights
The current therapy available does not treat the cause of Presbyopia but help treat its symptoms. Instead of targeting the eyes' lens, the drops make the eyes' pupils smaller, creating a pinhole effect that increases the depth of focus. In the case of presbyopia patients, pilocarpine is used to constrict the pupil. However, a miotic such as pilocarpine alone, unless selectively dosed, is problematic to use because of its side effects. These side effects include headache, redness, Ciliary spasm, brow ache, accommodation, and even uveitis. Another concern with miotics is their varying effects of onset, uration, and durability due to iris color. This could make driving at night dangerous.
Presbyopia Market Drivers
• Rising prevalence of Presbyopia
• An upsurge in launch of products
• Increasing lifestyle changes
• Increasing research in pharmaceutical treatment
• Increase in geriatric population
Presbyopia Market Barriers
• Rising healthcare costs
• Shortage of trained ophthalmologists
• Lack of accessibility of eye care services
• Limitations of Monovision
Browse More Related Reports of the Presbyopia Market Research Reports, click here for Presbyopia Market Forecast @ https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Presbyopia Market Report
• Coverage- 7MM
• Presbyopia Market Companies- AbbVie, Eyenovia, Orasis Pharmaceuticals, Novartis, Visus Therapeutics, LENZ Therapeutics, Glaukos Corporation, Ocuphire Pharma, and others.
• Presbyopia Pipeline Therapies- Phentolamine Opthalmic Solution 0.75%, Low dose pilocarpine, Pilocarpine HCl, CSF-1, Pilocarpine HCl Ophthalmic Solution, Pilocarpine HCl Ophthalmic Solution, Pilocarpine Ophthalmic, and others.
• Presbyopia Market Dynamics: Presbyopia Market Drivers and Barriers
• Presbyopia Market Access and Reimbursement, Unmet Needs, Future Perspectives
Read the Full Research Report of the Presbyopia Market Forecast Report, click here for Presbyopia Market Drivers and Barriers @ https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Report Introduction
3. Presbyopia Market Overview at a Glance
4. Presbyopia Market: Future Perspective
5. Executive Summary of Presbyopia
6. Key Events
7. Disease Background and Overview
8. Diagnosis of Presbyopia
9. Early Detection and Prevention of Presbyopia
10. Current Treatment Practices: Presbyopia
11. Guidelines of Presbyopia
12. Epidemiology and Patient Population
13. Patient Journey
14. Key Endpoints in Presbyopia Clinical Trials
15. Marketed Drugs
16. Emerging Drugs
17. Presbyopia: 7 Major Market Analysis
18. Market Access and Reimbursement
19. Key Opinion Leaders' Views
20. Market Drivers
21. Market Barriers
22. SWOT Analysis
23. Unmet Needs
24. Appendix
25. DelveInsight Capabilities
26. Disclaimer
27. About DelveInsight
Consult with our Business Expert regarding "Presbyopia Market Landscape" @ https://www.delveinsight.com/sample-request/presbyopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Trending Market Reports in 2023
Healthcare Partner Identification Services @ https://www.delveinsight.com/consulting/partner-identification-services
Medical Marijuana Market @ https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Oncolytic Virus Cancer Therapy Pipeline @ https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Overactive Bladder Syndrome Market @ https://www.delveinsight.com/report-store/overactive-bladder-market
Pediatric Growth Hormone Deficiency PGHD Market @ https://www.delveinsight.com/report-store/pediatric-growth-hormone-deficiency-market
Percutaneous Arterial Closure Device Market @ https://www.delveinsight.com/report-store/percutaneous-arterial-closure-device-market
Ranibizumab Biosimilars Insight @ https://www.delveinsight.com/report-store/ranibizumab-biosimilars-insight
Schistosomiasis Market @ https://www.delveinsight.com/report-store/schistosomiasis-market
Stem Cell Market @ https://www.delveinsight.com/report-store/stem-cell-market
Superficial Punctate Keratitis Market @ https://www.delveinsight.com/report-store/superficial-punctate-keratitis-market
Technical Due Diligence @ https://www.delveinsight.com/consulting/due-diligence-services
Transient Ischemic Attack Market @ https://www.delveinsight.com/report-store/transient-ischemic-attack-market
Wilms Tumor Market @ https://www.delveinsight.com/report-store/wilms-tumor-market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Presbyopia Market Size in 7MM was USD 17,883 Million in 2021 here
News-ID: 2987597 • Views: …
More Releases from DelveInsight Business Research
Global General Surgery Devices Market is expected to grow at a CAGR of 6.3% by 2 …
General Surgery Devices Market Overview
The Global General Surgery Devices Market is projected to grow at a CAGR of 6.34% from 2025 to 2032, driven by the rising burden of chronic diseases, increasing surgical interventions, and the adoption of robotic-assisted and minimally invasive techniques. Covering instruments such as handheld tools, electrosurgical devices, laparoscopic systems, wound closure products, and disposables, these devices play a critical role in diverse procedures, including orthopedic, cardiovascular,…
Intratumoral Cancer therapies Market Outlook 2034 - Clinical Trials, Market Size …
Intratumoral Cancer Market Summary
Intratumoral cancer therapies involve direct delivery into tumors, enabling localized targeting with minimal damage to surrounding tissue. Within the 7MM, non-melanoma cancers represent the largest share of cases and are expected to rise at ~2% annually, while in the US, breast cancer accounts for about 30% of cases with a growing incidence rate for intratumoral therapies. Currently, IMLYGIC is the only FDA-approved intratumoral therapy for melanoma, holding…
Bispecific and Trispecific Antibodies Market Projected to Experience Significant …
Bispecific antibodies represent an innovative class of therapies designed to address complex diseases by simultaneously binding two targets with a single molecule. Most currently approved bispecifics are for oncology, particularly multiple myeloma and diffuse large B-cell lymphoma (DLBCL). Beyond oncology, only HEMLIBRA and VABYSMO are approved for conditions such as hemophilia A, wet age-related macular degeneration, and diabetic macular edema, while KIMMTRAK is approved for uveal melanoma. The pipeline remains…
Narcolepsy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Update …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Narcolepsy pipeline constitutes 10+ key companies continuously working towards developing 12+ Narcolepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Narcolepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed…
More Releases for Presbyopia
Presbyopia Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Presbyopia Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Presbyopia pipeline landscape. It covers the Presbyopia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Presbyopia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Presbyopia…
Rising Geriatric Population Fuels Growth Of Myopia And Presbyopia Treatment Mark …
The Myopia and Presbyopia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Myopia and Presbyopia Treatment Market Size and Projected Growth Rate?
The market size for myopia and presbyopia treatment has witnessed substantial growth over several recent years. The market is projected…
Presbyopia Treatment Market Trends And Industry Forecast 2024-2031
Presbyopia Treatment Market: Trends Shaping the Industry
The presbyopia treatment market is experiencing significant growth, driven by a surge in the global aging population. As people live longer, the demand for effective solutions to age-related vision problems like presbyopia increases. This trend is fueling research and development efforts, leading to the introduction of innovative therapeutics like advanced contact lenses and eye drops.
Market Segmentation: Addressing Diverse Needs
The presbyopia treatment market is segmented…
Presbyopia Treatment Market Growth Analysis 2023-2030
Global Presbyopia Treatment Market Gains Momentum Amidst Rising Aging Population and Innovations in Therapeutics:
The global presbyopia treatment market has witnessed substantial growth in recent years, fueled by the increasing prevalence of presbyopia and the expanding aging population. Presbyopia, a common vision loss associated with aging, has prompted a surge in demand for effective treatments, leading to advancements in eyeglasses, contact lenses, surgeries, eye drops, and nutrient-based interventions.
Refractive surgeries, including Conductive…
Presbyopia Pipeline: Insights into Novel Pipeline Therapies, Key Pharma Companie …
DelveInsight's, "Presbyopia Pipeline Insight, 2022," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Presbyopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key takeaways from the Presbyopia Pipeline Insight Report
• Presbyopia Pipeline report offers a comprehensive…
Presbyopia Market 2020-2027 Sets the Table for Continued Growth || Top Growing C …
A transparent research method has been accomplished with the right tools and techniques to make this Presbyopia Market research report world-class. Two of the most widely used techniques namely SWOT analysis and Porter's Five Forces Analysis have been used while generating this report. Competitive analysis conducted in this report puts light on the moves of the key players in the Healthcare industry such as new product launches, expansions, agreements, joint…
